Epigenetic modifications: novel therapeutic strategies for systemic sclerosis?

MicroRNAs and epigenetics

(2011) Fumiaki Sato et al.   FEBS Journal

Pulmonary arterial hypertension in systemic sclerosis

(2010) Sevdalina Lambova et al.   AUTOIMMUNITY REVIEWS

Vascular alterations upon activation of TGFβ signaling in fibroblasts - implications for systemic sclerosis

(2010) Angelika Horn et al.   ARTHRITIS RESEARCH & THERAPY

Tyrosine Kinase Inhibitors in the Treatment of Systemic Sclerosis: From Animal Models to Clinical Trials

(2010) Naoki Iwamoto et al.   Current Rheumatology Reports

Tyrosine kinase inhibitors for the treatment of fibrotic diseases such as systemic sclerosis: towards molecular targeted therapies

(2009) J H W Distler et al.   ANNALS OF THE RHEUMATIC DISEASES

Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis

(2009) Hossein Hemmatazad et al.   ARTHRITIS AND RHEUMATISM

HDAC5 is a repressor of angiogenesis and determines the angiogenic gene expression pattern of endothelial cells

(2009) C. Urbich et al.   BLOOD

Isoform-specific histone deacetylase inhibitors: The next step?

(2009) Sriram Balasubramanian et al.   CANCER LETTERS

Aberrant DNA methylation in skin diseases

(2009) Yaping Li et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells

(2009) C Flotho et al.   LEUKEMIA

Innate immunity, epigenetics and autoimmunity in rheumatoid arthritis

(2009) Hanna Maciejewska Rodrigues et al.   MOLECULAR IMMUNOLOGY

Epigenetic inheritance during the cell cycle

(2009) Aline V. Probst et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Epigenetic control in rheumatoid arthritis synovial fibroblasts

(2009) Emmanuel Karouzakis et al.   Nature Reviews Rheumatology

HDAC expression and clinical prognosis in human malignancies

(2008) Wilko Weichert   CANCER LETTERS

Non-Invasive Tests in Animal Models and Humans: A New Paradigm for Assessing Efficacy of Biologics Including Prebiotics and Probiotics

(2008) R. Butler   CURRENT PHARMACEUTICAL DESIGN

Isoform-Selective Histone Deacetylase Inhibitors

(2008) Takayoshi Suzuki et al.   CURRENT PHARMACEUTICAL DESIGN

sirt1-null mice develop an autoimmune-like condition

(2008) Jedon Sequeira et al.   EXPERIMENTAL CELL RESEARCH

The many roles of histone deacetylases in development and physiology: implications for disease and therapy

(2008) Michael Haberland et al.   NATURE REVIEWS GENETICS

Treatment of Pulmonary Arterial Hypertension Due to Scleroderma: Challenges for the Future

(2008) Lewis J. Rubin   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Criteria to select molecular targets for anti-fibrotic therapy

(2008) J. H. W. Distler et al.   RHEUMATOLOGY

Making copies of chromatin: the challenge of nucleosomal organization and epigenetic information

(2008) Armelle Corpet et al.   TRENDS IN CELL BIOLOGY

Targeting histone deacetylase activity in rheumatoid arthritis and asthma as prototypes of inflammatory disease: should we keep our HATs on?

(2008) Aleksander M Grabiec et al.   ARTHRITIS RESEARCH & THERAPY